Combined Therapeutic Effects of I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer.

BACKGROUND

Owing to its combined effects, the co-delivery of different therapeutics is a promising option for the treatment of cancer. In the present study, tumor-targeting poly(ethylene glycol)-poly(lactic acid) (PEG-PLA) nanoparticles were developed for the transportation of two molecules, namely chemotherapeutic drug 5-fluorouracil (5Fu) and radionuclide iodine-131 (I), in a single platform.

METHODS

The obtained nanoparticles (Cetuximab [Cet]-PEG-PLA-5Fu-I) were spherical (diameter approximately 110 nm) and pH-sensitive. The targeting effect of nanoparticles via Cet was confirmed in colorectal cancer cells using a fluorescent assay. The combined effects of Cet-PEG-PLA-5Fu-I on cell viability and apoptosis were evaluated in colorectal cancer cells by Cell Counting Kit-8 and flow cytometry assays.

RESULTS

Blank nanoparticles (Cet-PEG-PLA) showed good biocompatibility, and Cet-PEG-PLA-5Fu-I nanoparticles were the most effective in terms of inhibition of cell viability and induction of apoptosis compared with monotherapy using Cet-PEG-PLA-5Fu or Cet-PEG-PLA-I. In the xenograft mouse model, compared with using Cet-PEG-PLA-5Fu or Cet-PEG-PLA-I alone, Cet-PEG-PLA-5Fu-I nanoparticles exhibited prolonged circulation in the blood and accumulation in the tumor, thus resulting in enhanced antitumor efficacy. Additionally, combined radio-chemotherapy with Cet-PEG-PLA-5Fu-I nanoparticles was associated with smaller tumor sizes than monotherapy, revealing the superior antitumor effects of Cet-PEG-PLA-5Fu-I nanoparticles. These effects were further evidenced by histological and immunohistochemical analyses.

CONCLUSION

The multifunctional Cet-PEG-PLA-5Fu-I nanoparticles are promising candidates for the co-delivery of 5Fu-mediated chemotherapy and I-mediated radiotherapy.